VANDA PHARMACEUTICALS INC's ticker is VNDA and the CUSIP is 921659108. A total of 180 filers reported holding VANDA PHARMACEUTICALS INC in Q3 2023. The put-call ratio across all filers is 3.16 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $678,901 | +901.3% | 157,153 | +1427.4% | 0.00% | – |
| Q2 2023 | $67,804 | -77.1% | 10,289 | -74.3% | 0.00% | -100.0% |
| Q4 2022 | $296,250 | +196.2% | 40,088 | +296.2% | 0.00% | – |
| Q3 2022 | $100,000 | -64.9% | 10,118 | -49.9% | 0.00% | -100.0% |
| Q2 2019 | $285,000 | -31.3% | 20,197 | -18.0% | 0.00% | 0.0% |
| Q1 2018 | $415,000 | +159.4% | 24,617 | +134.4% | 0.00% | – |
| Q4 2017 | $160,000 | -59.2% | 10,500 | -52.1% | 0.00% | -100.0% |
| Q3 2017 | $392,000 | +83.2% | 21,900 | -14.5% | 0.00% | +100.0% |
| Q1 2016 | $214,000 | -40.2% | 25,600 | -33.4% | 0.00% | -50.0% |
| Q4 2015 | $358,000 | -4.3% | 38,460 | +15.8% | 0.00% | -33.3% |
| Q3 2015 | $374,000 | +165.2% | 33,200 | +199.1% | 0.00% | +200.0% |
| Q2 2015 | $141,000 | -96.2% | 11,100 | -95.1% | 0.00% | -97.6% |
| Q1 2014 | $3,664,000 | +332.1% | 225,480 | +114.7% | 0.04% | +200.0% |
| Q2 2013 | $848,000 | – | 105,000 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Palo Alto Investors LP | 2,491,200 | $27,154,000 | 2.37% |
| Profit Investment Management, LLC | 281,890 | $3,071,000 | 2.26% |
| Sio Capital Management, LLC | 488,965 | $5,330,000 | 2.00% |
| Zebra Capital Management LLC | 14,766 | $161,000 | 0.47% |
| Prairiewood Capital, LLC | 50,165 | $547,000 | 0.43% |
| TANG CAPITAL MANAGEMENT LLC | 256,696 | $2,798,000 | 0.42% |
| HUSSMAN STRATEGIC ADVISORS, INC. | 156,000 | $1,700,000 | 0.29% |
| GLOBEFLEX CAPITAL L P | 100,843 | $1,099,000 | 0.27% |
| Epoch Investment Partners, Inc. | 2,757,646 | $30,059,000 | 0.18% |
| EMC Capital Management | 16,185 | $176,000 | 0.15% |